Next report date
Report period
Q1 2024
EPS estimate
−3.47MXN
Revenue estimate
1.42 BMXN
−3.85 BMXN
5.63 BMXN
198.56 M
Om BioCryst Pharmaceuticals, Inc.
Sektor
Bransch
VD
Jon P. Stonehouse
Webbplats
Huvudkvarter
Durham
Employees (FY)
536
Grundat
1986
FIGI
BBG00PGGX3N3
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
